24 Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ.Measurement of plasma norepinephrine and 3,4‐dihydroxyphenylglycol: method development for a translational research study. 23 Denfeld QE, Habecker BA, Woodward WR.Vasodilator effect of glucagon: receptorial crosstalk among glucagon, GLP‐1, and receptor for glucagon and GLP‐1. 22 Sélley E, Kun S, Szijártó IA, Kertész M, Wittmann I, Molnár GA.21 Murtagh JG, Binnion PF, Lal S, Hutchison KJ, Fletcher E.20 Ranganath L, Schaper F, Gama R, Morgan L.Glucagon‐induced densensitization: correlation between cyclic AMP levels and contractile force. Impaired responsiveness to the effect of glucagon on plasma adenosine 3′:5′‐cyclic monophosphate in normal man. 18 Hendy GN, Tomlinson S, O’Riordan JL.Experimental designs balanced for the estimation of residual effects of treatments. Five algorithms that calculate cardiac output from the arterial waveform: a comparison with Doppler ultrasound. Zeitschrift für die gesamte experimentelle Medizin. Vergleichende Bestimmungen des Minutenvolumens des Herzens beim Menschen mittels der Stickoxydulmethode und durch Blutdruckmessung. Data acquisition from S/5 GE Datex anesthesia monitor using VSCapture: An open source.NET/Mono tool. Esmolol, an ultrashort‐acting, selective beta 1‐adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties. 12 Volz‐Zang C, Eckrich B, Jahn P, Schneidrowski B, Schulte B, Palm D.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Management of beta‐adrenergic blocker and calcium channel antagonist toxicity. Glucagon in beta‐blocker and calcium channel blocker overdoses: a systematic review. A potential role for glucagon in the treatment of drug‐induced symptomatic bradycardia. 8 Love JN, Sachdeva DK, Bessman ES, Curtis LA, Howell JM.Glucagon for the treatment of symptomatic beta blocker overdose. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Goldfrank’s toxicologic emergencies, 10th ed. In: Hoffman RS, Lewin NA, Nelson L, Goldfrank LR, Flomenbaum N, eds. Hemodynamic effects of glucagon in portal hypertension.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |